Home ETF List About

ETF Holdings Breakdown of BMY

Stock NameBloomsbury Publishing Plc
TickerBMY(GBX) LSE
TYPECommon Stock
CountryUK
ISINGB0033147751
LEI213800ZL2PEC4C6UOQ53

BMY institutional holdings

The following institutional investment holdings of BMY have been identified

Date ETF ISIN/Name Num Shares Book value
2025-09-25 IE00B5BMR087 (iShares Core S&P 500 UCITS ETF USD (Acc)) 4,807,405USD 208,689,451
2025-09-25 IE00BD8KRH84 (iShares Core S&P 500 UCITS ETF GBP Hedged (Dist)) 4,807,405USD 208,689,451
2025-09-25 IE00BL3J3G74 (iShares Core S&P 500 UCITS ETF MXN Hedged (Acc)) 4,807,405USD 208,689,451
2025-09-25 IE00B4L5Y983 (iShares Core MSCI World UCITS ETF USD (Acc)) 3,113,404USD 135,152,868
2025-09-25 IE00BD45YS76 (iShares Core MSCI World UCITS ETF GBP Hedged (Dist)) 3,113,404USD 135,152,868
2025-09-25 IE00BKBF6H24 (iShares Core MSCI World UCITS ETF) 3,113,404USD 135,152,868
2025-09-25 IE000OHHIBC6 (iShares Core MSCI World UCITS ETF USD (Dist)) 3,113,404USD 135,152,868
2025-09-25 IE00BHZPJ890 (iShares MSCI USA ESG Enhanced UCITS ETF USD (Dist)) 1,738,377 0.7%USD 75,462,946 -1.1%
2025-09-25 IE0031442068 (iShares Core S&P 500 UCITS ETF USD (Dist)) 721,345USD 31,313,586
2025-09-25 IE00B6R52259 (iShares MSCI ACWI UCITS ETF) 548,462USD 23,808,735 -1.7%
2025-09-25 IE00019GPKX6 (iShares MSCI ACWI UCITS ETF SGD Hedged (Acc)) 548,462USD 23,808,735
2025-09-25 IE00BFNM3G45 (iShares MSCI USA ESG Screened UCITS ETF USD (Acc)) 600,026 0.1%USD 26,047,129 -1.7%
2025-09-25 IE00BFNM3H51 (iShares MSCI USA ESG Screened UCITS ETF USD (Dist)) 600,026USD 26,047,129
2025-09-25 IE000G2LIHG9 (iShares MSCI USA ESG Screened UCITS ETF EUR Hedged (Acc)) 600,026USD 26,047,129
2025-09-24 IE00BMTX1Y45 (iShares S&P 500 Swap UCITS ETF USD (Acc)) 11,735USD 518,218
2025-09-24 IE000D3BWBR2 (iShares S&P 500 Swap UCITS ETF USD (Dist)) 11,735USD 518,218
2025-09-25 IE00B0M62Q58 (iShares MSCI World UCITS ETF USD (Dist)) 219,062USD 9,509,481
2025-09-25 IE00B3ZW0K18 (iShares S&P 500 EUR Hedged UCITS ETF (Acc)) 327,204USD 12,164,540
2025-09-25 IE00BHZPJ569 (iShares MSCI World ESG Enhanced UCITS ETF USD Acc GBP) 270,920USD 11,760,637
2025-09-25 IE00BG11HV38 (iShares MSCI World ESG Enhanced UCITS ETF USD Inc GBP) 270,920USD 11,760,637
2025-09-25 IE00BP3QZB59 (iShares Edge MSCI World Value Factor UCITS ETF) 516,900USD 22,438,629
2025-09-25 IE00BFYTYS33 (iShares Edge MSCI World Value Factor UCITS USD Dist) 516,900USD 22,438,629 -1.7%
2025-09-25 IE00BFNM3K80 (iShares MSCI World ESG Screened UCITS ETF USD (Dist)) 153,616USD 6,668,471 -1.7%
2025-09-25 IE00BFNM3J75 (iShares MSCI World ESG Screened UCITS ETF) 153,616USD 6,668,471
2025-09-25 IE0003WV2ME7 (iShares S&P 500 Equal Weight UCITS ETF GBP Hedged (Acc)) 194,557USD 8,445,719
2025-09-25 IE000MLMNYS0 (iShares S&P 500 Equal Weight UCITS ETF USD (Acc)) 194,557USD 8,445,719
2025-09-25 IE00B8FHGS14 (iShares Edge MSCI World Minimum Volatility UCITS ETF USD (Acc)) 167,244USD 7,260,062
2025-09-25 IE00BGPP8L80 (iShares Edge MSCI World Minimum Volatility UCITS ETF GBP Hedged (Acc)) 167,244USD 7,260,062
2025-09-25 IE00B441G979 (iShares MSCI World EUR Hedged UCITS ETF (Acc)) 135,261USD 5,028,630
2025-09-25 IE00B43HR379 (iShares S&P 500 Health Care Sector UCITS ETF USD (Acc)) 963,578USD 41,828,921
2025-09-25 IE00BMBKBZ46 (iShares S&P 500 Health Care Sector UCITS ETF) 963,578USD 41,828,921
2025-09-25 IE00BD1F4M44 (iShares Edge MSCI USA Value Factor UCITS ETF USD (Acc) GBP) 532,656 0.6%USD 23,122,597 -1.2%
2025-09-25 IE00BFF5RX68 (iShares Edge MSCI USA Value Factor UCITS ETF USD (Dist)) 532,656 0.6%USD 23,122,597 -1.2%
2025-09-25 IE00B52SFT06 (iShares MSCI USA UCITS ETF USD (Acc)) 86,641USD 3,761,086
2025-09-25 IE00B14X4M10 (iShares MSCI North America UCITS ETF USD (Dist) USD) 42,475USD 1,843,840
2025-09-25 IE00BYZK4776 (iShares Healthcare Innovation UCITS ETF USD (Acc)) 301,230USD 13,076,394
2025-09-25 IE00BKVL7778 (iShares Edge MSCI World Minimum Volatility ESG UCITS ETF USD (Acc)) 11,362USD 493,224
2025-09-25 IE00BJ5JNZ06 (iShares MSCI World Health Care Sector ESG UCITS ETF) 72,513USD 3,147,789 -1.7%
2025-09-25 IE0009QS7W62 (iShares MSCI World Health Care Sector ESG UCITS ETF USD (Acc)) 72,513USD 3,147,789
2025-09-25 IE00BMXC7V63 (iShares S&P 500 Paris-Aligned Climate UCITS ETF USD (Acc)) 46,970USD 2,038,968
2025-09-25 IE000G4PH2B1 (iShares S&P 500 Paris-Aligned Climate UCITS ETF USD Dist) 46,970USD 2,038,968
2025-09-25 IE00B3Y8X563 (iShares S&P 500 GBP Hedged UCITS ETF (Acc)) 50,015USD 1,626,513
2025-09-25 IE00BZ0PKT83 (iShares Edge MSCI World Multifactor UCITS ETF USD (Acc) GBP) 49,893USD 2,165,855
2025-09-25 IE00BYXPXK00 (iShares STOXX World Equity Multifactor UCITS ETF EUR Hedged (Acc)) 49,893USD 2,165,855
2025-09-25 IE000R9FA4A0 (iShares S&P 500 ESG UCITS ETF USD (Acc)) 38,894USD 1,688,389
2025-09-25 IE00BN92ZL31 (iShares MSCI World Paris-Aligned Climate UCITS ETF USD (Dist)) 24,519USD 1,064,370
2025-09-25 IE00BMXC7W70 (iShares MSCI World Paris-Aligned Climate UCITS ETF USD (Acc)) 24,519USD 1,064,370
2025-09-25 IE00BKVL7331 (iShares Edge MSCI USA Minimum Volatility ESG UCITS ETF USD (Acc)) 8,559USD 371,546
2025-09-25 IE000OKVTDF7 (iShares MSCI USA Value Factor ESG UCITS ETF USD (Acc)) 35,129USD 1,524,950
2025-09-25 IE00B42YS929 (iShares MSCI World GBP Hedged UCITS ETF (Acc)) 12,803USD 416,360 -0.9%
2025-09-25 IE000NITTFF2 (iShares Russell 1000 Growth UCITS ETF) 5,741USD 249,217
2025-09-25 IE00BZ0PKS76 (iShares STOXX USA Equity Multifactor UCITS ETF USD (Acc)) 13,402USD 581,781
2025-09-25 IE00BG13YZ23 (iShares Edge MSCI USA Multifactor UCITS ETF USD (Dist)) 13,402USD 581,781
Total =39,543,937 USD 1,713,053,418
Book value of shares is calculated on the adjusted close price of each day (row).

News associated with BMY

Bristol Myers Squibb Company (NYSE:BMY) Receives $56.38 Average Target Price from Brokerages
Bristol Myers Squibb Company (NYSE:BMY – Get Free Report) has received a consensus recommendation of “Hold” from the twenty-one ratings firms that are currently covering the firm, MarketBeat reports. One analyst has rated the stock with a sell rating, fifteen have given a hold rating, four have given a buy rating and one has given […] - 2025-09-18 02:44:51
Bloomsbury Publishing (LON:BMY) Given Buy Rating at Berenberg Bank
Bloomsbury Publishing (LON:BMY – Get Free Report)‘s stock had its “buy” rating reiterated by investment analysts at Berenberg Bank in a research note issued to investors on Wednesday, Marketbeat.com reports. They presently have a GBX 825 price objective on the stock. Berenberg Bank’s price target would indicate a potential upside of 67.51% from the stock’s […] - 2025-08-29 02:19:10
SCHD, COP, HD, BMY: Large Outflows Detected at ETF
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the Schwab US Dividend Equity ETF (Symbol: SCHD) where we have detected an approximate $141.7 million dollar outflow -- that's a 0.2% decrease week over - 2025-08-22 11:49:23
Nigel Newton Sells 50,867 Shares of Bloomsbury Publishing Plc (LON:BMY) Stock
Bloomsbury Publishing Plc (LON:BMY – Get Free Report) insider Nigel Newton sold 50,867 shares of the firm’s stock in a transaction on Tuesday, August 12th. The stock was sold at an average price of GBX 476 ($6.46), for a total transaction of £242,126.92 ($328,798.10). Bloomsbury Publishing Stock Performance LON BMY opened at GBX 479 ($6.50) […] - 2025-08-14 02:13:06
Penny Scott-Bayfield Sells 33,185 Shares of Bloomsbury Publishing Plc (LON:BMY) Stock
Bloomsbury Publishing Plc (LON:BMY – Get Free Report) insider Penny Scott-Bayfield sold 33,185 shares of the company’s stock in a transaction on Tuesday, August 12th. The shares were sold at an average price of GBX 476 ($6.43), for a total transaction of £157,960.60 ($213,258.54). Bloomsbury Publishing Stock Up 1.2% BMY stock opened at GBX 478.50 […] - 2025-08-13 02:18:46
Daiwa America Downgrades Bristol Myers Squibb (NYSE:BMY) to Hold
Bristol Myers Squibb (NYSE:BMY – Get Free Report) was downgraded by stock analysts at Daiwa America from a “strong-buy” rating to a “hold” rating in a research report issued to clients and investors on Tuesday,Zacks.com reports. A number of other analysts have also weighed in on the company. Wall Street Zen lowered Bristol Myers Squibb […] - 2025-08-07 05:05:00
Bristol Myers Squibb (NYSE:BMY) Downgraded by Daiwa Capital Markets to “Neutral”
Daiwa Capital Markets downgraded shares of Bristol Myers Squibb (NYSE:BMY – Free Report) from an outperform rating to a neutral rating in a report issued on Tuesday morning, MarketBeat.com reports. Daiwa Capital Markets currently has $42.00 target price on the biopharmaceutical company’s stock. Several other research firms have also issued reports on BMY. UBS Group […] - 2025-08-06 04:39:04
John Bason Acquires 11,677 Shares of Bloomsbury Publishing Plc (LON:BMY) Stock
Bloomsbury Publishing Plc (LON:BMY – Get Free Report) insider John Bason purchased 11,677 shares of Bloomsbury Publishing stock in a transaction on Friday, August 1st. The stock was purchased at an average price of GBX 471 ($6.26) per share, for a total transaction of £54,998.67 ($73,126.80). Bloomsbury Publishing Trading Up 0.3% LON BMY opened at […] - 2025-08-06 02:11:10
Notable ETF Outflow Detected - SCHD, CVX, BMY, LMT
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the Schwab US Dividend Equity ETF (Symbol: SCHD) where we have detected an approximate $97.6 million dollar outflow -- that's a 0.1% decrease week over - 2025-08-04 11:50:25
Citigroup Cuts Bristol Myers Squibb (NYSE:BMY) Price Target to $47.00
Bristol Myers Squibb (NYSE:BMY – Free Report) had its price target lowered by Citigroup from $51.00 to $47.00 in a report published on Friday morning,Benzinga reports. The brokerage currently has a neutral rating on the biopharmaceutical company’s stock. Other analysts also recently issued reports about the company. The Goldman Sachs Group restated a “neutral” rating […] - 2025-08-04 02:22:52
Notable Thursday Option Activity: FDS, BMY, HPQ
Looking at options trading activity among components of the S&P 500 index, there is noteworthy activity today in FactSet Research Systems Inc. (Symbol: FDS), where a total volume of 1,422 contracts has been traded thus far today, a contract volume which is representative of - 2025-07-31 14:20:57
Bristol-Myers Squibb Co. Q2 Profit Decreases, But Beats Estimates
(RTTNews) - Bristol-Myers Squibb Co. (BMY) released a profit for second quarter that Decreased from last year but beat the Street estimates. - 2025-07-31 08:46:07
Bristol Myers Squibb Names Cristian Massacesi Chief Medical Officer
(RTTNews) - Bristol Myers Squibb (BMY) Friday said it appointed Cristian Massacesi as Executive Vice President, Chief Medical Officer, and Head of Development, effective August 1, 2025. - 2025-07-25 08:23:26
37,683 Shares in Bristol Myers Squibb Company (NYSE:BMY) Bought by Massachusetts Financial Services Co. MA
Massachusetts Financial Services Co. MA acquired a new stake in Bristol Myers Squibb Company (NYSE:BMY – Free Report) in the first quarter, HoldingsChannel reports. The institutional investor acquired 37,683 shares of the biopharmaceutical company’s stock, valued at approximately $2,298,000. A number of other hedge funds and other institutional investors also recently made changes to their […] - 2025-07-21 05:51:00
Bristol Myers Squibb, Pfizer Announce Direct-to-patient Option For Eliquis
(RTTNews) - Bristol Myers Squibb (BMY) and Pfizer (PFE) Thursday announced a direct-to-patient option for purchasing their blood thinner medicine, Eliquis through the partnership's patient resource Eliquis 360 Support. - 2025-07-17 08:36:08
Validea Detailed Fundamental Analysis - BMY
Below is Validea's guru fundamental report for BRISTOL-MYERS SQUIBB CO (BMY). Of the 22 guru strategies we follow, BMY rates highest using our Multi-Factor Investor model based on the published strategy of Pim van Vliet. This multi-factor model seeks low volatility stocks that a - 2025-07-07 10:36:26
Allspring Global Investments Holdings LLC Trims Position in Bristol Myers Squibb Company (NYSE:BMY)
Allspring Global Investments Holdings LLC cut its holdings in shares of Bristol Myers Squibb Company (NYSE:BMY – Free Report) by 6.1% during the 1st quarter, according to its most recent Form 13F filing with the SEC. The firm owned 182,510 shares of the biopharmaceutical company’s stock after selling 11,935 shares during the period. Allspring Global […] - 2025-07-04 04:52:25
ONEY, BMY, CAH, F: Large Inflows Detected at ETF
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR Russell 1000 Yield Focus ETF (Symbol: ONEY) where we have detected an approximate $203.7 million dollar inflow -- that's a 24.3% increase week o - 2025-06-30 11:52:45
Pre-Market Most Active for Jun 27, 2025 : TSLL, BBAI, QS, SQQQ, BMY, NVDA, TQQQ, AMD, RILY, NKE, SRFM, OKLO
The NASDAQ 100 Pre-Market Indicator is up 79.58 to 22,526.87. The total Pre-Market volume is currently 68,987,998 shares traded.The following are the most active stocks for the pre-market session: Direxion Daily TSLA Bull 2X Shares (TSLL) is +0.09 at $12.53, with 5,406,480 share - 2025-06-27 09:29:54
Nilsine Partners LLC Lowers Stake in Bristol Myers Squibb Company (NYSE:BMY)
Nilsine Partners LLC reduced its position in shares of Bristol Myers Squibb Company (NYSE:BMY – Free Report) by 9.0% during the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 5,751 shares of the biopharmaceutical company’s stock after selling 568 shares during […] - 2025-06-23 06:41:00
Exchange Traded Concepts LLC Sells 2,703 Shares of Bristol Myers Squibb Company (NYSE:BMY)
Exchange Traded Concepts LLC decreased its holdings in shares of Bristol Myers Squibb Company (NYSE:BMY – Free Report) by 12.0% during the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 19,880 shares of the biopharmaceutical company’s stock after selling 2,703 shares during the quarter. Exchange […] - 2025-06-19 05:22:53
VictoryShares Free Cash Flow ETF -- Insider Buying Index Registering 11.9%
A look at the weighted underlying holdings of the VictoryShares Free Cash Flow ETF (Symbol: VFLO) shows an impressive 11.9% of holdings on a weighted basis have experienced insider buying within the past six months. Bristol Myers Squibb Co. (Symbol: BMY), which makes up 3.11% - 2025-06-17 10:32:19
Wedge Capital Management L L P NC Sells 511,384 Shares of Bristol-Myers Squibb (NYSE:BMY)
Wedge Capital Management L L P NC lowered its position in Bristol-Myers Squibb (NYSE:BMY – Free Report) by 99.2% during the first quarter, according to its most recent Form 13F filing with the SEC. The fund owned 4,014 shares of the biopharmaceutical company’s stock after selling 511,384 shares during the period. Wedge Capital Management L […] - 2025-06-12 05:38:53
Notable ETF Inflow Detected - MGV, BRK.A, DHR, BMY
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the Vanguard Mega Cap Value ETF (Symbol: MGV) where we have detected an approximate $142.0 million dollar inflow -- that's a 1.6% increase week over week - 2025-06-11 12:07:56
Bristol-Myers Squibb (NYSE:BMY) Holdings Boosted by Vest Financial LLC
Vest Financial LLC grew its stake in shares of Bristol-Myers Squibb (NYSE:BMY – Free Report) by 73.5% in the 1st quarter, Holdings Channel reports. The firm owned 16,912 shares of the biopharmaceutical company’s stock after acquiring an additional 7,166 shares during the quarter. Vest Financial LLC’s holdings in Bristol-Myers Squibb were worth $1,031,000 as of […] - 2025-06-09 05:50:54
Bristol-Myers Squibb (NYSE:BMY) Cut to “Buy” at Wall Street Zen
Wall Street Zen lowered shares of Bristol-Myers Squibb (NYSE:BMY – Free Report) from a strong-buy rating to a buy rating in a research report report published on Friday. A number of other research analysts have also recently commented on the stock. The Goldman Sachs Group restated a “neutral” rating and set a $55.00 price target […] - 2025-06-09 02:44:47
Two Sigma Investments LP Sells 4,635,617 Shares of Bristol-Myers Squibb (NYSE:BMY)
Two Sigma Investments LP lowered its stake in shares of Bristol-Myers Squibb (NYSE:BMY – Free Report) by 98.2% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 85,624 shares of the biopharmaceutical company’s stock after selling 4,635,617 shares during the quarter. Two […] - 2025-05-28 05:04:56
Validea Detailed Fundamental Analysis - BMY
Below is Validea's guru fundamental report for BRISTOL-MYERS SQUIBB CO (BMY). Of the 22 guru strategies we follow, BMY rates highest using our Multi-Factor Investor model based on the published strategy of Pim van Vliet. This multi-factor model seeks low volatility stocks that a - 2025-05-26 10:38:17
Notable ETF Inflow Detected - VT, BRK.A, C, BMY
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the Vanguard Total World Stock ETF (Symbol: VT) where we have detected an approximate $1.3 billion dollar inflow -- that's a 3.1% increase week over week - 2025-05-06 12:13:06
Bristol-Myers Squibb (NYSE:BMY) Reaches New 12-Month High Following Insider Buying Activity
Bristol-Myers Squibb (NYSE:BMY – Get Free Report)’s share price reached a new 52-week high during mid-day trading on Wednesday following insider buying activity. The stock traded as high as $50.35 and last traded at $50.21, with a volume of 15941007 shares traded. The stock had previously closed at $49.22. Specifically, EVP Samit Hirawat acquired 4,250 […] - 2025-05-02 02:51:01

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.